New Market Study: "Familial Adenomatous Polyposis Coli - Pipeline Review, H2 2012"
Global Markets Direct's, 'Familial Adenomatous Polyposis Coli - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Familial Adenomatous Polyposis Coli, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Familial Adenomatous Polyposis Coli. Familial Adenomatous Polyposis Coli - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release